Evidence for immune reactivity against neoplasms.
D000818:Animals; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D000941:Antigens; D000951:Antigens, Neoplasm; D000956:Antigens, Viral; D001665:Binding Sites; D002051:Burkitt Lymphoma / Q000276:immunology; D002277:Carcinoma / Q000276:immunology; D002478:Cells, Cultured; D000939:Epitopes; D006801:Humans; D007109:Immunity; D007111:Immunity, Cellular; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology; D008545:Melanoma / Q000276:immunology; D051379:Mice; D009369:Neoplasms / Q000276:immunology*; D009858:Oncogenic Viruses / Q000276:immunology; D011817:Rabbits; D012509:Sarcoma / Q000276:immunology; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D000906:Antibodies; D000941:Antigens; D000951:Antigens, Neoplasm; D000956:Antigens, Viral; D000939:Epitopes; D014316:Tritium; D013936:Thymidine